Abstract:Qi Lou, 1, &ast Lu Pan, 1, &ast Shengjin Xiang, 1, 2, &ast Yueting Li, 1 Jiahui Jin, 1 Jingyang Tan, 1 Baoshan Huang, 1, 2 Kaihui Nan, 1, 2 Sen Lin 1, 2 1 National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, 325027, People's Republic of China; 2 State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, 325027, People's Republic of China &astThese authors contributed equally to this work Correspondence: Kaihui Nan; Sen Lin, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, People's Republic of China, Tel +86-577-88067962, Email ; Introduction: Benzalkonium chloride (BAC) is widely employed as a preservative in eye drops, which will cause the death of corneal epithelial cells due to ROS production, DNA strand breakage, and mitochondrial dysfunction, resulting in dry eye disease (DED)-like changes in ocular surface tissues. In this study, Melatonin (MT) liposomes (TAT-MT-LIPs) designed by loading MT into TAT-modified liposomes have been developed, characterized, and used for inhibiting BAC-induced DED (BAC-DED). Methods: The TAT was chemically grafted onto the Mal-PEG 2000 -DSPE by Michael's addition between the sulfhydryl group in TAT and the maleimide group in Mal-PEG 2000 -DSPE. TAT-MT-LIPs were prepared using film dispersion followed by the extrusion method and topically treated in rats once a day. BAC-DED was induced in rats by topical administration with 0.2% BAC twice daily. Defects, edema, and inflammation of the corneas, as well as IOP, were examined. Histologic analyses of corneas were performed to assess the change of mitochondrial DNA oxidation and NLRP3/Caspase-1/GSDMD signaling transduction. Results: After topical administration, TAT-MT-LIPs significantly alleviated DED-clinical symptoms of experimental animals by inhibiting tissue inflammation and preventing the loss of the corneal epithelium and conjunctival goblet cells. Our data suggested continuous ocular surface exposure of BAC-induced NLRP3/Caspase-1/GSDMD mediated corneal epithelium pyroptosis, which was not reported before. BAC caused substantial mt-DNA oxidation, which promoted the transduction of NLRP3/Caspase-1/GSDMD and consequent corneal epithelium pyroptosis. TAT-MT-LIPs could efficiently suppress the BAC-induced corneal epithelium pyroptosis and inflammation by inhibiting mt-DNA oxidation and the subsequent signal transmission. Conclusion: NLRP3/Caspase-1/GSDMD mediated corneal epithelium pyroptosis is involved in the development of BAC-DED. The present study provided new insights into the adverse effects of BAC, which can serve as a new target for protecting corneal epithelium when applying BAC as a preservative in eye drops. The developed TAT-MT-LIPs can efficiently inhibit BAC-DED and give great potential to be developed as a new DED treatment. Keywords: melatonin liposome, dry eye disease, benzalkonium chloride, pyroptosis, NLRP3/Caspase-1/GSDMD signaling axis Benzalkonium chloride (BAC) is widely employed as a preservative in eye drops. 1 Increasing pieces of evidence have proved that consistent exposure to BAC causes dry eye disease (DED)-like changes in ocular surface tissues (eg, corneal epithelium defect, conjunctival goblet cell loss, tear film instability, and persistence ocular surface inflammation), 2–4 nevertheless the mechanism underly is still largely unclear. DED is the leading ocular surface disease in morbidity in ophthalmic clinics, 5 which affects up to 30% of worldwide populations. 6 Tear film hyperosmolarity and tissue inflammation are generally recognized as critical risk factors in DED. 7 Tear film hyperosmolarity induces the overproduction of reactive oxygen species (ROS), which leads to continuingly oxidative damage to the bio-molecules (DNA, proteins, and lipids) and causes ocular surface inflammation. 8 The inflammation in the ocular surface improves the evaporation of tear, which aggravates tear film hyperosmolarity and generates additional tissues inflammation (namely as the "vicious cycle of inflammation"). 9 Zheng et al have observed on a dry eye animal model and a hypertonic cell (human corneal epithelial cells) model that the ROS in corneal epithelium enhanced the expression (both gene and protein level) of pyrin domain (PYD)-containing protein 3 (NLRP3) and promoted the secretion of IL-1β which re -Abstract Truncated-

IL-1β induced down-regulation of miR-146a-5p promoted pyroptosis and apoptosis of corneal epithelial cell in dry eye disease through targeting STAT3

The role of the JAK/STAT3 signaling pathway in acquired corneal diseases

NLRP12- and NLRC4-mediated corneal epithelial pyroptosis is driven by GSDMD cleavage accompanied by IL-33 processing in dry eye.

KCNK5 Regulating Potassium Efflux and Inducing Pyroptosis in Corneal Epithelial Cells Through TNFSF10-Mediated Autophagy in Dry Eye

Role of Inhibiting Inflammation of LC3-Associated Phagocytosis in Dry Eye Disease

IFN-γ Facilitates Corneal Epithelial Cell Pyroptosis Through the JAK2/STAT1 Pathway in Dry Eye

Calcitriol Alleviates Hyperosmotic Stress-Induced Corneal Epithelial Cell Damage via Inhibiting the NLRP3–ASC–Caspase-1–GSDMD Pyroptosis Pathway in Dry Eye Disease

Dexamethasone Attenuates Dry Eye-Induced Pyroptosis by Regulating the Kcnq1ot1/Mir-214 Cascade

Effect of Topical Programmed Death-Ligand1 on Corneal Epithelium in Dry Eye Mouse

WAY-100635 Alleviates Corneal Lesions Through 5-HT1A Receptor-ROS-Autophagy Axis in Dry Eye

Imbalanced IL-37/TNF-α/CTSS signaling disrupts corneal epithelial barrier in a dry eye model in vitro

Hyperosmolarity promotes macrophage pyroptosis by driving the glycolytic reprogramming of corneal epithelial cells in dry eye disease

Role of the Cirs-7/Mir-7 Axis in the Regulation of Proliferation, Apoptosis and Inflammation of Chondrocytes Induced by IL-1β.

The expression of miRNA‐146a‐5p and its mechanism of treating dry eye syndrome

MiR-155 is Involved in Renal Ischemia-Reperfusion Injury via Direct Targeting of FoxO3a and Regulating Renal Tubular Cell Pyroptosis.

Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.

Interleukin-20 is involved in dry eye disease and is a potential therapeutic target

Suppression of NLRP3/Caspase-1/GSDMD Mediated Corneal Epithelium Pyroptosis Using Melatonin-Loaded Liposomes to Inhibit Benzalkonium Chloride-Induced Dry Eye Disease

S100A9-TLR4 axis aggravates dry eye through the blockage of autophagy

DZ2002 alleviates corneal angiogenesis and inflammation in rodent models of dry eye disease via regulating STAT3-PI3K-Akt-NF-κB pathway

Single-cell landscape reveals the epithelial cell-centric pro-inflammatory immune microenvironment in dry eye development